TY  - JOUR
AU  - Paniagua Herranz, Lucía
AU  - Doger, Bernard
AU  - Díaz Tejeiro, Cristina
AU  - Sanvicente García, Adrián
AU  - Nieto Jiménez, Cristina
AU  - Moreno, Víctor
AU  - Pérez Segura, Pedro
AU  - Gyorffy, Balazs
AU  - Calvo, Emiliano
AU  - Ocana, Alberto
PY  - 2023
DO  - 10.3390/cancers15123250
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/103633
T2  - Cancers
AB  - Background: The identification of proteins in the cellular membrane of the tumoral cell is a key to the design of therapeutic agents. Recently, the bi-specific antibody amivantamab, targeting the oncogenic membrane proteins EGFR and MET, received...
LA  - eng
M2  - 1
PB  - MDPI
KW  - EGFR
KW  - MET
KW  - Bi-specific antibodies
KW  - Anti-PD-L1
KW  - Pancreatic adenocarcinoma
KW  - Prostate adenocarcinoma
KW  - Immune checkpoint therapies
TI  - Genomic Mapping of Epidermal Growth Factor Receptor and Mesenchymal–Epithelial Transition-Up-Regulated Tumors Identifies Novel Therapeutic Opportunities
TY  - journal article
VL  - 15
ER  -